B, B., CJ, v. d. L., IA, S., T, D., JW, D., & AE, V. (2025). Longitudinal assessment of circulating fibroblast activation protein in systemic sclerosis-associated interstitial lung disease. Arthritis research & therapy, 27(1), 184. https://doi.org/10.1186/s13075-025-03656-y
Chicago Style (17th ed.) CitationB, Broens, van der Laken CJ, Simons IA, Dekker T, Duitman JW, and Voskuyl AE. "Longitudinal Assessment of Circulating Fibroblast Activation Protein in Systemic Sclerosis-associated Interstitial Lung Disease." Arthritis Research & Therapy 27, no. 1 (2025): 184. https://doi.org/10.1186/s13075-025-03656-y.
MLA (9th ed.) CitationB, Broens, et al. "Longitudinal Assessment of Circulating Fibroblast Activation Protein in Systemic Sclerosis-associated Interstitial Lung Disease." Arthritis Research & Therapy, vol. 27, no. 1, 2025, p. 184, https://doi.org/10.1186/s13075-025-03656-y.